Company Profile | ![]() | 0-9 | ![]() | A | ![]() | B | ![]() | C | ![]() | D | ![]() | E | ![]() | F | ![]() | G | ![]() | H | ![]() | I | ![]() | J | ![]() | K | ![]() | L | ![]() | M | ![]() | N | ![]() | O | ![]() | P | ![]() | Q | ![]() | R | ![]() | S | ![]() | T | ![]() | U | ![]() | V | ![]() | W | ![]() | X | ![]() | Y | ![]() | Z |
BioLineRX
(NASDAQ: BLRX)
|
8:00 PM UTC, 04/11/25 | |||
---|---|---|---|---|
Last: $2.75 | Change: +0.32 | %Change: +13.17% | Volume: 24,555 |
Period | Eps Estimate |
Eps Actual |
Prev-Year Actual |
Date/Time (ET) |
---|---|---|---|---|
Q4 2024 | -0.81 | -1.60 | -7.64 | 31-Dec-24 |
Q3 2024 | -1.74 | 0.00 | -0.30 | 30-Sep-24 |
Q2 2024 | -3.01 | 0.00 | -0.30 | 30-Jun-24 |
Q1 2024 | -11.66 | 0.00 | -0.15 | 31-Mar-24 |
Period | Eps Estimate |
Eps Actual |
Prev-Year Actual |
Date/Time (ET) |
---|---|---|---|---|
Q1 2025 | -0.95 | n.a. | 0.00 | 31-Mar-25 |